{"SPADE_UN_29024": {"Sequence Information": {"Peptide Name": "P5", "Sequence": "NVTLLCDCPNGPWVWVPAFC", "Sequence Length": 20, "Biological Activity": ["Antiviral"], "Binding Target": "1. Virus replication\n2. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q9WGY8", "uniprotUrl": "http://www.uniprot.org/uniprot/Q9WGY8", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.", "Pubmed ID": "21543477", "Reference": "J Virol. 2011;85:7037-7047", "Author": "Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21543477"}], "Mass": 2234.62, "PI": 4.05, "Net Charge": -1, "Hydrophobicity": 0.7, "Frequent Amino Acids": "CPV", "Absent Amino Acids": "EHIKMOQRSUY", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 10, "Polar Residues": 10, "Positive Residues": 0, "Negative Residues": 1, "SPADE ID": "SPADE_UN_29024", "Similar Sequences": [{"SPADE_ID": "SPADE_N_10101", "Similarity": 1.0, "Sequence": "WDRGNVTLLCDCPNGPWVWVPAFCQAVG"}, {"SPADE_ID": "SPADE_UN_13989", "Similarity": 1.0, "Sequence": "TGEKVWDRGNVTLLCDCP"}, {"SPADE_ID": "SPADE_UN_14032", "Similarity": 1.0, "Sequence": "PTGERVWDRGNVTLLCDCPN"}], "Hemolytic Activity": "", "Target Organism": "HIV-1 92UG029(IC50 REP=5.05µM),HIV-1 NL4-3(IC50 REP=5.72µM),HIV-1 SF33(IC50 REP=3.84µM),HIV-1 YU2(IC50 REP=7.3µM),HIV-1 JRCSF(IC50 REP=85.08µM),HIV-1 92TH026(IC50 REP=>100µM),HIV-1 92BR025(IC50 REP=>100µM),HIV-1 92UG035(IC50 REP=>100µM),HIV-1 92UG024(IC50 REP=0.71µM),HIV-1 93BR029(IC50 REP=>100µM),HIV-1 93BR020(IC50 REP=94.35µM),HIV-1 RU570(IC50 REP=1.96µM),HIV-1 V1557(IC50 REP=80.54µM),Simian immunodeficiency virus (SIV) mac251(IC50 REP=>100µM),HIV-2(IC50 REP=>100µM)"}}}